Pin Zhang

A Nation-Wide multicenter 10-year (1999-2008) retrospective clinical epidemiological study of female breast cancer in china

Jing Li, Bao‐Ning Zhang, Jin‐Hu Fan et al. · BMC Cancer · 2011 · 234 citations · Full text

Medicine, Oncology, Cancer Epidemiology +8

Phase I Study and Biomarker Analysis of Pyrotinib, a Novel Irreversible Pan-ErbB Receptor Tyrosine Kinase Inhibitor, in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer

Fei Ma, Qiao Li, Shanshan Chen et al. · Journal of Clinical Oncology · 2017 · 234 citations

Medicine, Oncology, Pharmacology +17

A Critical Function of Th17 Proinflammatory Cells in the Development of Atherosclerotic Plaque in Mice

Qi Gao, Yang Jiang, Tian Ma et al. · The Journal of Immunology · 2010 · 218 citations · Full text

Veterinary Medicine, Immunology, Pathology +17

Dalpiciclib or placebo plus fulvestrant in hormone receptor-positive and HER2-negative advanced breast cancer: a randomized, phase 3 trial

Binghe Xu, Qingyuan Zhang, Pin Zhang et al. · Nature Medicine · 2021 · 169 citations

Medicine, Oncology, Pharmacology +12

In Real Life, Low-Level HER2 Expression May Be Associated With Better Outcome in HER2-Negative Breast Cancer: A Study of the National Cancer Center, China

Yiqun Li, Nilupai Abudureheiyimu, Hongnan Mo et al. · Frontiers in Oncology · 2022 · 119 citations · Full text

Medicine, Oncology, Pathology +17